Curing Cancer Could Be Close

Podcast: Most Innovative Companies · Fast Company

Opublikowano: 2026-10-14

Stéphane Bancel has been CEO of Moderna since 2011, but it’s almost as if he's led three different companies in the past five years. First came the pandemic sprint: A biotech with no commercial products became a household name, manufacturing a billion vaccine doses in 2021 and generating roughly $18 billion in annual sales. Then, the descent. As demand for COVID shots collapsed, revenue fell roughly 90%, its stock price plunged, and Bancel had to cut thousands of jobs. Now comes another turn. Positive results from a melanoma trial with Merck have sent Moderna's stock sharply higher ove...